Baxter Declares Quarterly Dividend
Baxter Declares Quarterly Dividend
DEERFIELD, Ill. - 2024-05-07
伊利諾伊州迪爾菲爾德-2024-05-07
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on July 1, 2024, to stockholders of record as of May 31, 2024. The indicated annual dividend rate is $1.16 per share of common stock.
全球醫療技術領導者百特國際公司（紐約證券交易所代碼：BAX）今天宣佈，其董事會已宣佈季度現金分紅爲每股普通股0.29美元。股息將於2024年7月1日支付給截至2024年5月31日的登記股東。規定的年度股息率爲普通股每股1.16美元。
About Baxter
關於巴克斯特
Every day, millions of patients, caregivers and healthcare providers rely on Baxter's leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For more than 90 years, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on X/Twitter, LinkedIn and Facebook.
每天，數百萬患者、護理人員和醫療保健提供者依賴 Baxter 領先的診斷、重症監護、腎臟護理、營養、醫院和外科產品組合，這些產品廣泛應用於患者家庭、醫院、醫生辦公室和其他護理場所。90 多年來，我們一直在關鍵的十字路口開展業務，在這裏，拯救和維持生命的創新與實現這一目標的醫療保健提供者相遇。百特在全球100多個國家提供產品、數字健康解決方案和療法，他們現在正在公司豐富的醫學突破傳統基礎上再接再厲，推動下一代變革性的醫療保健創新。要了解更多信息，請訪問 www.baxter.com 然後關注我們 X/推特， 領英 和 Facebook。
This release includes forward-looking statements concerning the company's capital allocation, which currently includes the issuance of quarterly dividends. These forward-looking statements are based on assumptions about many factors and it is possible that Baxter's annual dividend payout rate may differ, possibly materially, from the anticipated annual indicative dividend described herein. For information about some of the risks and important factors that could affect Baxter's future results, financial condition and liquidity, see Baxter's most recent filings on Forms 10-K and 10-Q and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements unless otherwise required by the federal securities laws.
本新聞稿包括有關公司資本配置的前瞻性陳述，目前包括季度股息的發行。這些前瞻性陳述基於對許多因素的假設，百特的年度股息支付率可能與此處描述的預期年度指示性股息存在重大差異，甚至可能存在重大差異。有關可能影響百特未來業績、財務狀況和流動性的一些風險和重要因素的信息，請參閱百特最新的10-K和10-Q表以及其他美國證券交易委員會文件，所有這些文件均可在百特網站上查閱。除非聯邦證券法另有要求，否則百特不承諾更新其前瞻性陳述。
Baxter is a registered trademark of Baxter International Inc.
Baxter 是百特國際公司的註冊商標。
譯文內容由第三人軟體翻譯。